PTC Therapeutics Inc (PTCT) — Cash Flow Reinvestment Rate
PTC Therapeutics Inc (PTCT) has a Cash Flow Reinvestment Rate of 0.21x as of March 2025, reinvesting $186.89 Million (capex $2.53 Million plus investments $-184.36 Million) from operating cash flow of $870.10 Million. See PTCT cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
PTC Therapeutics Inc Cash Flow Reinvestment Rate (2025–2025)
Historical reinvestment intensity for PTC Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see PTC Therapeutics Inc cash flow conversion.
Annual Cash Flow Reinvestment Rate for PTC Therapeutics Inc (2025–2025)
Year-by-year capital reinvestment analysis for PTC Therapeutics Inc. See PTCT free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.80x | $570.90 Million | $711.20 Million | $8.86 Million | — |